DM
Therapeutic Areas
NeuroGT Pipeline
| Drug | Indication | Phase |
|---|---|---|
| MPS I (Hurler Syndrome) Program | Hurler Syndrome (MPS I) | Pre-clinical |
| MPS II (Hunter Syndrome) Program | Hunter Syndrome (MPS II) | Pre-clinical |
| MPS III (Sanfilippo Syndrome) Program | Sanfilippo Syndrome (MPS III) | Pre-clinical |